Category: Approval

TOKYO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OM?src=hash" target="_blank"gt;#OMlt;/agt;–Solasia Pharma K.K. (TOKYO:4597, Headquarters:Tokyo, Japan, President &
CEO:Yoshihiro Arai, hereinafter “Solasia”)…

DUBLIN–(BUSINESS WIRE)–The “Methycobal
Tablets – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Methycobal Tablets Drug Insight, 2019 highlights the
drug marketed details and the G…

DUBLIN–(BUSINESS WIRE)–The “Sevikar
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Sevikar Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

DUBLIN–(BUSINESS WIRE)–The “Sipralexoro
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Sipralexoro Drug Insight, 2019 highlights the drug
marketed details and the Global API Manu…

DUBLIN–(BUSINESS WIRE)–The “Skelaxin
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Skelaxin Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufactur…

DUBLIN–(BUSINESS WIRE)–The “Tracleer
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Tracleer Drug Insight, 2019 highlights the drug
marketed details and the Global API Manufactur…

DUBLIN–(BUSINESS WIRE)–The “Erbitux
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Erbitux Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

DUBLIN–(BUSINESS WIRE)–The “Amitiza
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

Amitiza Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…

DUBLIN–(BUSINESS WIRE)–The “BeneFIX
– Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s
offering.

BeneFIX Drug Insight, 2019 highlights the drug marketed
details and the Global API Manufacturer…